中国组织工程研究 ›› 2018, Vol. 22 ›› Issue (12): 1895-1901.doi: 10.3969/j.issn.2095-4344.0208

• 组织构建实验造模 experimental modeling in tissue construction • 上一篇    下一篇

门静脉动脉化治疗大鼠急性肝衰竭

陈  鹏,江  艺,张小进   

  1. 解放军南京军区福州总院肝胆外科,福建省福州市  350025
  • 收稿日期:2017-11-12 出版日期:2018-04-28 发布日期:2018-04-28
  • 通讯作者: 江艺,主任医师,解放军南京军区福州总院肝胆外科,福建省福州市 350025
  • 作者简介:陈鹏,解放军南京军区福州总院肝胆外科,福建省福州市 350025

Portal vein arterialization for acute hepatic failure in rats

Chen Peng, Jiang Yi, Zhang Xiao-jin   

  1. Department of Hepatobiliary Surgery, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, Fujian Province, China
  • Received:2017-11-12 Online:2018-04-28 Published:2018-04-28
  • Contact: Jiang Yi, Chief physician, Department of Hepatobiliary Surgery, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, Fujian Province, China
  • About author:Chen Peng, Department of Hepatobiliary Surgery, Fuzhou General Hospital of Nanjing Military Command, Fuzhou 350025, Fujian Province, China

摘要:

文章快速阅读:

文题释义:
门静脉动脉化:是指通过腹腔内便于应用的动脉将动脉血引入门静脉,通过提高门静脉血供改善肝脏功能的方法。20世纪50年代,Cohn(1952年)和Fisher(1954年)为增加门腔分流术后导致的肝脏血流灌注不足、改善肝功能,首次提出门静脉动脉化这一创新理念,目前已将其应用于肝移植、肝门部胆管肿瘤、胰腺肿瘤、胆囊肿瘤、各种原因导致的门静脉高压门体分流 等手术中,特别是对于肝移植、肝门部胆管肿瘤和胆囊肿瘤,有较多成功案例报道。
摘要
背景:
部分门静脉动脉化可通过增加肝脏血供的方式减缓急性肝衰竭的发展。
目的:观察部分门静脉动脉化对肝衰竭模型大鼠肝脏功能及病理学变化的影响。
方法:将130只SD大鼠随机分为3组,动脉化组(n=50)切除左肾,以同种异体腹主动脉血管为移植材料,采用套入式缝合及袖套法建立门静脉动脉化模型,造模成功后一次性腹腔注射D-氨基半乳糖1 300 mg/kg,诱导急性肝功能衰竭;肝衰竭组(n=50)切除左肾,游离门静脉,阻断门静脉16 min后开放,关闭腹腔后一次性腹腔注射D-氨基半乳糖1 300 mg/kg,诱导急性肝功能衰竭;对照组(n=30)切除左肾,阻断门静脉    16 min后开放,关闭腹腔后一次性腹腔注射生理盐水1 300 mg/kg。术后12,24,36,48,72 h,观察各组血清学及肝脏组织病理变化。
结果与结论:①动脉化组与肝衰竭组均造模成功30只,术后72 h成活率分别为70%、53%,组间比较差异有显著性意义(P < 0.05);对照组术后72 h存活率为100%;②对照组不同时间点的血清门冬氨酸转氨酶、丙氨酸转氨酶、白细胞介素6、肿瘤坏死因子水平α及门静脉内毒素水平均低于其余两组(P < 0.05);动脉化组术后不同时间点的血清门冬氨酸转氨酶、丙氨酸转氨酶低于肝衰竭组(P < 0.05),术后24-72 h的总胆红素、白细胞介素6、肿瘤坏死因子水平α及门静脉内毒素水平均低于肝衰竭组(P < 0.05),36-72 h的白蛋白低于肝衰竭组(P < 0.05);③术后72 h,对照组肝脏结构完整;肝衰竭组正常肝小叶结构已破坏,大量炎细胞浸润;动脉化组病变清于肝衰竭组;④结果表明,门静脉动脉化可在一定程度上上改善肝脏功能,减缓肝衰竭的发展。

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程
ORCID: 0000-0002-0049-7171(陈鹏)

关键词: 门静脉动脉化, 急性肝衰竭, D-氨基半乳糖, 套入式缝合及袖套法, 部分门静脉动脉化, 门冬氨酸转氨酶, 丙氨酸转氨酶, 总胆红素, 白蛋白, 组织构建

Abstract:

BACKGROUND: Partial portal vein arterialization (PPVA) can slow the progression of liver failure by increasing the blood supply.
OBJECTIVE: To explore the effects of PPVA on the liver function and pathological changes in a rat model of liver failure.
METHODS: Totally 130 Sprague-Dawley rats were randomized into three groups: PPVA group (n=50) underwent left nephrectomy, the PPVA model was established by sleeve suturing and cuff technology, and then D-galactosamine was intraperitoneally administered at the dose of 1 300 mg/kg to induce acute liver failure; liver failure group (n=50) underwent left nephrectomy, the portal vein was dissociated, ligated for 16 minutes and then mobilized, and D-galactosamine was intraperitoneally administered at the dose of 1 300 mg/kg to induce acute liver failure after abdominal closure; control group (n=30) received left nephrectomy, the portal vein was ligated for 16 minutes and then mobilized, and same volume of normal saline was intraperitoneally administered after abdominal closure. The serological and pathological changes of the liver tissue were observed at 12, 24, 36, 48 and 72 postoperative hours.
RESULTS AND CONCLUSION: Animal models (n=30 per group) were made successfully, the survival rate was 70% and 53%, respectively, and there was a significant difference between two groups after modeling (P < 0.05). The survival rate in the control group was 100% at 72 postoperative hours. The serum levels of glutamic-oxalacetic transaminease, alanineaminotranferase, interleukin 6, tumor necrosis factor α, and endotoxin in the portal vein in the control group were significantly lower than those in the other two groups at different time points postoperatively (P < 0.05). In the PVA group, the serum levels of glutamic-oxalacetic transaminease and alanineaminotranferase at postoperative different time points postoperatively, the serum levels of total bilrubin, interleukin 6, tumor necrosis factor α, and endotoxin level in the portal vein at 24-72 postoperative hours, and albumin at 36-72 postoperative hours were significantly lower than those in the liver failure group (P < 0.05). At 72 postoperative hours, the liver structure was complete in the control group, hepatic lobules were damaged accompanied with abundant inflammatory cell infiltration in the liver failure group and the pathological lesions were improved in the PVA group. To conclude, PVA can improve liver function and slow the progression of liver failure to certain extents.

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松组织工程

Key words: Liver Failure, Acute, Alanine Transaminase, Bilirubin

中图分类号: